-->

Berita Kocar Kacir

Motivasi Menulis
Home » Penelusuran Italia

The Old Lady Not Have Primadona

TURIN - Juventus Attacante, Mirko Vucinic said that no one in his team's leading players. According Vucinic all colleagues have an important contribution to the success of the Bianconeri during the 2012-13 season wading.

The Old Lady look awesome when host AC Milan in Turin in Coppa Italia quarter-finals on Thursday (01/10/2013) early this morning. Yes, Juve managed to win by a nose over Milan with a final score of 2-1.

Rossoneri actually managed to lead through goals Stephan El Shaarawy in the 6th minute. However, the team was made by Antonio Conte scored twice with Sebastian Giovinco in the 13th minute and Vucinic in injury time. The victory took Juve to advance to the semifinal Coppa Italia.

"There is no prima donna at Juventus. Every player here exert their best from the first minute until the final minutes of the game, "said Vucinic, as reported Skysport Italy, Thursday (10/01/2013).

Vucinic who appeared to replace the role of Giovinco in the 65th minute it was added that the success of Juve beat Milan as well as unyielding spirit possessed his team.

"The character that makes this team to be unique," he continued.

When asked about his physical condition, a former retainer of AS Roma's claims that he is not yet in top form. Because, Vucinic has just returned from an injury that happened some time ago.

"I have not been in the best level. So far I am still growing conditions. I need to work hard to keep fit in order to perform for 90 minutes, "he concluded.
(rin)

Scholarship S-2 vaccinology in Italy

JAKARTA - Faculty of Medicine, University of Siena, Italy, offering scholarships Master (S-2) in the field of vaccinology and clinical pharmacy. The scholarship program titled Master Programme in Vaccinology and Pharmaceutical Clinical Development is a joint Faculty of Medicine, University of Siena, with Novartis Vaccines and Diagnostics, Novartis Vaccines Institute for Global Health (NVGH), and the Advanced Immunization Technologies (Aditec).

Scholarships will be awarded to qualified applicants, including researchers involved in the development of vaccines funded European & Developing Countries Clinical Trials Partnership (EDCTP). Participants attending the program will be for one year at the University of Siena and a six-month internship at Novartis. This program will provide those interested in public health and infectious diseases opportunity to study the use of vaccines to prevent the disease, the impact of immunization, vaccine development and the role of stakeholders in policy on vaccines and immunization, studies focusing on developing countries.

The program will also include lectures on the practice of hospital-owned universities and other academic institutions. In addition, participants had the opportunity to practice in various areas of research on vaccines, including experimental vaccine manufacture.

Master Programme in Clinical Vaccinology and Pharmaceutical Development aims to build the capacity of researchers in vaccinology and vaccine development in developing countries. The program prepares students in the prospects of a career in academia, public health and especially in research and development, and institutional private vaccine.

Applicants must be graduates of medical science, particularly medicine with clinical experience in the medical field for a minimum of two years and a maximum of five years. Good English skills, in writing or orally, is also a major requirement.

Application documents received by February 5, 2013. More information can be listened to on the page or Aditec EDCTP. (RFA)
Back To Top